BONUSCAP-ZERTIFIKAT - FRESENIUS Share Price

Certificat

DE000HD3PRY3

Market Closed - Bid/Ask 01:16:21 18/05/2024 am IST
35.93 EUR -0.94% Intraday chart for BONUSCAP-ZERTIFIKAT - FRESENIUS
Current month+4.58%
1 month+11.74%
Date Price Change
18/24/18 35.93 -0.94%
16/24/16 36.27 -0.66%
15/24/15 36.51 +0.36%
14/24/14 36.38 -0.55%
13/24/13 36.58 +0.16%

Real-time BOERSE MUENCHEN

Last update May 18, 2024 at 01:16 am IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HD3PRY
ISINDE000HD3PRY3
Date issued 14/03/2024
Strike 42
Maturity 20/12/2024 (217 Days)
Parity 1 : 1
Emission price 29.97
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 36.85
Lowest since issue 27.86
Spread 0.04
Spread %0.11%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.94 EUR
Average target price
36.41 EUR
Spread / Average Target
+30.30%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW